Loading...

Overview

New York’s 2019 legislative session introduces several bills that would reduce instances of surprise billing or balance billing, including legislation that would require insurers to cover services provided by out-of-network providers and legislation that would promote transparency by requiring providers to submit bills to patients before services are provided. Several bills address pharmaceutical pricing, including legislation that would prohibit drug tiers based on the expense of disease category and charging cost-sharing percentages for prescriptions. Additional proposed legislation address transparency for pharmacy benefit managers (PBMs), including legislation that would require PBMs to disclose information such as the aggregate amount of rebates received.

In the 2017-2018 session, Governor Andrew M. Cuomo presented a proposal to combat rising prescription drug prices. In sum, the Governor wants to 1) impose a price ceiling for certain high-cost prescription drugs reimbursed through Medicaid; 2) place a surcharge on high-priced drugs priced above certain benchmarks; and 3) require pharmacy benefit managers to register with the State, and be subject to new regulations. In addition, New York developed an all-payer claims database (APCD), and has recently released draft regulations that are open for public comment.  The state passed legislation in 2011 that enables the creation of an all-payer database. The all-player database will integrate claims data from the APCD  with clinical and quality data and public health repositories. Other current New York legislation is mostly aimed at pharmaceutical price transparency, patient fee advisement, and provider-insurance carrier contract provisions.

In other price transparency measures, 2017-2018 legislation sought to require pharmaceutical companies to disclose historical information about a drug’s development if a drug exceeds a certain wholesale acquisition cost threshold. Another bill would require health care providers to advise patients of fees the patient will be charged for upcoming services. New York also proposed an interesting bill that aimed to educate New Yorkers on long-term care options, insurance, and insurance providers. In regard to cost containment, New York sought to prohibit health insurance plans and clauses that impose drug tiers based on expense or disease or that require a provider to acquiesce to a health insurance carrier reimbursing the provider at the lowest rate the provider has charged another person or entity for the same service.

The State Database

The Source tracks state activities impacting healthcare price and competition in both legislation and litigation in a searchable database to help stakeholders at the state level understand their legal and regulatory environment as they make efforts to improve access, quality, and efficiency, and reduce costs in healthcare.

LEGISLATION: The Database of State Laws Impacting Healthcare Cost and Quality (SLIHCQ), created by The Source on Healthcare Price & Competition and Catalyst for Payment Reform, catalogues state legislation governing price transparency, provider market power, provider payment, provider networks, and benefit design. The database also includes pharmaceutical legislation beginning in the 2017-2018 legislative session. *Note: Current legislative session bill updates are ongoing. Check back weekly for updates. 

LITIGATION: The Source tracks major litigation and antitrust enforcement action by federal entities (FTC or DOJ), state attorney generals, and private parties in the main provider and insurer markets, particularly legal challenges of healthcare consolidation and anticompetitive contract provisions. Additionally, the database contains major pharmaceutical cases including legislation challenges and significant appellate cases.

Search the database across all jurisdictions on the State Overview page, or view and filter existing legislation or litigation on individual state pages. The database allows customized search and filter by keyword, status, and/or key issue category. *Multiple filter/selections enabled. Click here for User Guide.

 

Filter by Key Issue, Year, or Status
Download User Guide

© 2018-2019 The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.
Filter by Key Issue
Download User Guide

© 2018-2019 The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.
Filter by Key Issue

Additional Resources

LEGISLATIVE CALENDAR

New York’s current legislative session runs from 1/9/2019 – 1/8/2020. Bills from 2019 will carry over to 2020 as part of the 2019-2020 legislative term.

FY 2020 BUDGET

New York’s fiscal year begins April 1 and ends on March 31. However, the actual “budget cycle,” representing the time between early budget preparation and final disbursements, begins some nine months earlier and lasts approximately 27 months – until the expiration of the State Comptroller’s authority to honor vouchers against the previous fiscal year’s appropriations. New York passed its FY 2020 Budget on March 31, 2019. The governor’s health care overview of the executive budget is available here. New York’s FY 2020 budget codifies provisions of the Affordable Care Act into state law, including protections for people with pre-existing conditions, requirements for all insurers to cover the 10 essential health benefits, and prohibitions against discriminatory benefit designs. The budget also continues the FY 2018 Medicaid drug expenditure cap provision that allows the state Department of Health to set an annual projected spending target for prescription drugs, with some modifications.

HEALTHCARE INITIATIVES

  • New York’s Department of Health administers its Certificate of Need process, which governs establishment, construction, renovation and major medical equipment acquisitions of health care facilities, such as hospitals, nursing homes, home care agencies, and diagnostic and treatment centers. As explained by the DOH: “The objectives of the CON process are to promote delivery of high quality health care and ensure that services are aligned with community need. CON provides the Department of Health oversight in limiting investment in duplicate beds, services and medical equipment which, in turn, limits associated health care costs.”

ANTITRUST ENFORCEMENT

  • On April 24, 2015, the FTC announced that it had sent a letter to the state of New York, expressing its concerns that the state’s certificate of public advantage (COPA) laws, which purport to bestow antitrust immunity on certain healthcare collaborations, were unnecessary because federal antitrust enforcement already considers whether consolidation benefits consumers. The FTC further explained that it was concerned that the COPA laws would be used to immunize transactions with anticompetitive effects, and that this would result in higher health care prices for consumers.
  • The Attorney General and UnitedHealth Group entered into a settlement in January 2016 following the AG’s investigation of the health care organization for unlawfully restraining competition related to insurance for elder and long-term-care homes. According to the AG press release, the settlement provides that “United may not require skilled nursing facilities seeking to participate in United’s broader insurance network to also contract with United for a separate service – United’s institutional special needs plan.” The investigation stemmed from complaints that United was requiring skilled nursing facilities to participate in the special needs plans to be included in the broader United network. By doing this, United allegedly was cutting off competition to other special needs plans.

RESEARCH & ARTICLES

  • The New York State Health Foundation has developed a program area in Empowering Health Care Consumers. This program came out of the organization’s work examining hospital price variation, price transparency and what price information consumers want, and developing a consumer-facing healthcare price tool for New Yorkers.
  • A 2016 report on encouraging value-based healthcare competition puts the spotlight on healthcare consolidation in New York.
  • In 2014, the New York legislature passed the Emergency Services and Balance Billing Law (“Surprise Billing” law). Five years post-enactment, a study assesses the implementation of the law and how its unique “baseball-style” arbitration approach to settling payment disputes is working for stakeholders.

KEY RESOURCES